COMMUNIQUÉS West-GlobeNewswire

Innovation Pharmaceuticals Granted End-of-Phase 2 Meeting
24/10/2018
BEVERLY, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has [...]
Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference
24/10/2018
The U.S. Court of Appeals for the Federal Circuit has affirmed the decision of the Patent Trial and Appeal Board in the U.S. patent interference proceeding The appeal of the European EP2801355 patent opposition [...]
XBiotech Announces Dismissal of Securities Class Action Suit
24/10/2018
AUSTIN, Texas, Oct. 24, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that the honorable Judge Dustin M. Howell of the 459 th Travis County District Court has issued a letter ruling granting the [...]
CO2 GRO Announces Positive Michigan Flower Grow Trials Using CO2 Foliar Spray Technology
24/10/2018
TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“ GROW ”) (TSX-V: GROW) is pleased to announce a series of positive flower grow trials using dissolved CO2 spray versus no CO2 gassing at a [...]
FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
24/10/2018
myPTM Allows Patients to Personalize Their Treatment by Delivering On-Demand Boluses, or Drug Doses, Within Therapeutic Limits Set by Their Physician DUBLIN - October 24, 2018 - Medtronic plc (NYSE:MDT) today announced [...]
The Eye Institute of Utah Among First in U.S. to Offer Visian Toric ICL
24/10/2018
Salt Lake City, UT, Oct. 24, 2018 (GLOBE NEWSWIRE) -- The Eye Institute of Utah , a comprehensive eye care practice and leading surgical eye center in the Intermountain West, announces plans to offer Visian Toric ICL [...]
Bio-on grants bioplastic technology license to Russian group TAIF for production in Russia. 17.6 million Euro agreement
24/10/2018
A highly important agreement for technological and commercial relations between Italy and Russia was signed in Moscow in the presence of Russian Federation President Vladimir Putin and Italy's Prime Minister Giuseppe [...]
Long-term incentive program
24/10/2018
Company Announcement No. 17/2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. [...]
Medibio Signs ilumen™ Corporate Contract with a Large Australian Employer
24/10/2018
SYDNEY, Australia and MINNEAPOLIS, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, announces a contract for the latest release of [...]
Aptevo Therapeutics Announces Expanded Growth Initiatives for IXINITY
24/10/2018
Plans to Introduce 3000 IU IXINITY Assay for Enhanced Patient Convenience Will Commence Pediatric Study Seeking U.S. Label Expansion Explores Ex-US Licensing and Partnership Collaborations to Expand International [...]
MediPharm Labs Corp. Announces Grant of Stock Options
24/10/2018
TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) is pleased to announce that the board of directors of the Company has approved the granting of options [...]
Teligent, Inc. Announces FDA Approval of Desoximetasone Ointment USP 0.05%
24/10/2018
BUENA, N.J., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Hemispherx to Present at the Dawson James Securities 4th Annual Small Cap Growth Conference
24/10/2018
ORLANDO, Fla., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, today [...]
Carequality Trusted Exchange Framework Facilitates Exchange Of Nearly 60 Million Clinical Documents in First Two Years
24/10/2018
Members and Non-Members Encouraged to Engage with Nation’s Leading Interoperability Framework VIENNA, Va., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Carequality , a national-level, trusted exchange framework to enable health [...]
Judge Denies Teva Pharmaceuticals’ Motion to Dismiss Corcept Therapeutics’ Allegations of Patent Infringement
24/10/2018
MENLO PARK, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]
Inovio Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 8, 2018
24/10/2018
PLYMOUTH MEETING, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it will host a conference call and live webcast to report its 2018 third quarter financial results [...]
Neos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry Meeting
24/10/2018
DALLAS and FORT WORTH, Texas, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will present new data for Adzenys XR-ODT (amphetamine) Extended-Release Orally- [...]
Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints
24/10/2018
Pivotal phase 3 trials of SM04690 in knee osteoarthritis anticipated to begin early 2019 SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Samumed announced today top-line data from its phase 2b trial of SM04690 in knee [...]
Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)
24/10/2018
PRINCETON, N.J., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced an oral presentation regarding predictors of pregnancy in the Phase 3 SECURE [...]

Pages